ADTX News and Press, ADiTx Therapeutics Inc. From 11/30/21

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the launch of an underwritten public offering. Dawson James Securities, Inc. is acting as sole book-running manager for the o...

AditxtScore™ will be used for Assessing Immune Status for COVID-19 Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company that improves the health of the immune system, announced today that the Johnson...

Gainers: Altamira (NASDAQ:CYTO) +68%. Wunong (NASDAQ:WNW) +52%. Everspin Technologies (NASDAQ:MRAM) +44%. SOC Telemed (NASDAQ:TLMD) +33%. Bit Brother  (NASDAQ:BTB) +31%. Kura Sushi USA (NASDAQ:KRUS) +27%. Brilliant Earth Group (NASDAQ:BRLT) +26%. Xponential Fitness (NYSE:XPOF) +23%....

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), has announced a webinar at 2pm ET this afternoon to discuss its earlier announcement today. All investors are invited to attend, whether professional or individual. On today’s webinar, CEO Amro Albanna will be sharing ...

Gainers: Altamira Therapeutics (NASDAQ:CYTO) +82%, SOC Telemed (NASDAQ:TLMD) +16%, Sundial Growers (NASDAQ:SNDL) +16%, Beyond Air (NASDAQ:XAIR) +15%, IM Cannabis (NASDAQ:IMCC) +13%. Losers: Oncorus (NASDAQ:ONCR) -43%, Acutus Medical (NASD...

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced that the global Phase 3 PRESECO (PREventing SEvere COVID-19) trial evaluating oral Avigan®/Reeqonus™ (favipiravir...

Aditxt (NASDAQ:ADTX) announces a partnership with CLX Health, a developer of cloud-based solutions. The goal of the partnership is to accelerate the market availability of AditxtScore for COVID-19 through CLX Health’s TrustAssure Solution Suite. Aditxt will be ...

Access to over 5,000 U.S. Locations Reaching 15,000 Locations Globally in over 81 countries worldwide Service to dozens of airlines that enter over 75 countries Aditxt, Inc. (Nasdaq: ADTX), (“Aditxt” or the “Company”) a bio...

Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the closing of its previously announced underwritten public offering of 2,833,333 shares of its common stock at a public offering...

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the Company’s Co-Founder, Chairman, and CEO Amro Albanna will present at the Dawson J...